Literature DB >> 19675223

Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality.

Rafael Zaragoza1, Javier Pemán, Guillermo Quindós, Jose R Iruretagoyena, María S Cuétara, Paula Ramírez, Maria D Gómez, Juan J Camarena, Angel Viudes, José Pontón.   

Abstract

The influence of kinetic patterns of Candida albicans germ tube antibodies (CAGTA) on mortality was analyzed in six intensive care units. Statistically significant lower mortality rates were found in patients with patterns of increasing CAGTA titers who had been treated with antifungal agents. Thus, antifungal treatment should be considered when CAGTA titers are increasing in critically ill patients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19675223      PMCID： PMC2756852          DOI： 10.1128/CVI.00183-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  11 in total

1.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

Authors:  Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden
Journal:  Clin Infect Dis       Date:  2006-05-16       Impact factor: 9.079

2.  Antibodies to Candida albicans germ tubes in two intensive care patients with invasive candidiasis.

Authors:  J R Iruretagoyena; P Regúlez; G Quindós; J Pontón
Journal:  Rev Iberoam Micol       Date:  2000-09       Impact factor: 1.044

Review 3.  Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.

Authors:  Rafael Zaragoza; Javier Pemán
Journal:  Rev Iberoam Micol       Date:  2006-06       Impact factor: 1.044

4.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Specific antibody response in a patient with Candida dubliniensis fungemia.

Authors:  R Salesa; M D Moragues; R Sota; J Pemán; G Quindós; J Pontón
Journal:  Rev Iberoam Micol       Date:  2001-03       Impact factor: 1.044

Review 6.  Is there a role for antibody testing in the diagnosis of invasive candidiasis?

Authors:  Guillermo Quindós; María Dolores Moragues; José Pontón
Journal:  Rev Iberoam Micol       Date:  2004-03       Impact factor: 1.044

7.  Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis.

Authors:  Claudia Montagnoli; Silvia Sandini; Angela Bacci; Luigina Romani; Roberto La Valle
Journal:  Med Mycol       Date:  2004-08       Impact factor: 4.076

8.  [Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis].

Authors:  María Dolores Moragues; Natalia Ortiz; José Ramón Iruretagoyena; Juan Carlos García-Ruiz; Elena Amutio; Almudena Rojas; Joaquín Mendoza; Guillermo Quindós; José Pontón-San Emeterio
Journal:  Enferm Infecc Microbiol Clin       Date:  2004-02       Impact factor: 1.731

9.  Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients.

Authors:  R Zaragoza; J Pemán; G Quindós; J R Iruretagoyena; M S Cuétara; P Ramírez; M D Gómez; J J Camarena; A Viudes; J Pontón
Journal:  Clin Microbiol Infect       Date:  2009-05-11       Impact factor: 8.067

Review 10.  Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis.

Authors:  Sébastien Gibot
Journal:  Crit Care       Date:  2005-06-03       Impact factor: 9.097
View more
  4 in total

1.  Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.

Authors:  P Pini; C Bettua; C F Orsi; C Venturelli; F Forghieri; S Bigliardi; L Faglioni; F Luppi; L Serio; M Codeluppi; M Luppi; C Mussini; M Girardis; Elisabetta Blasi
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

2.  β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.

Authors:  Estrella Martín-Mazuelos; Ana Loza; Carmen Castro; Desirée Macías; Ismail Zakariya; Pedro Saavedra; Sergio Ruiz-Santana; Elena Marín; Cristóbal León
Journal:  Intensive Care Med       Date:  2015-07-02       Impact factor: 17.440

3.  Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.

Authors:  Javier Pemán; Rafael Zaragoza; Guillermo Quindós; Miriam Alkorta; María S Cuétara; Juan J Camarena; Paula Ramírez; María J Giménez; Estrella Martín-Mazuelos; María J Linares-Sicilia; José Pontón
Journal:  BMC Infect Dis       Date:  2011-03-09       Impact factor: 3.090

4.  Biomarkers of fungal infection: Expert opinion on the current situation.

Authors:  E Bouza; B Almirante; J García Rodríguez; J Garnacho-Montero; M Salavert; P Muñoz; M Sanguinetti
Journal:  Rev Esp Quimioter       Date:  2019-11-14       Impact factor: 1.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.